BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7676234)

  • 21. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary mutations in the p53 tumor suppressor gene; significance for clinical practice. National Work Group Hereditary Mamma Carcinoma].
    Menko FH; Nooy MA; Vasen HF
    Ned Tijdschr Geneeskd; 1996 Jun; 140(26):1347-50. PubMed ID: 8710022
    [No Abstract]   [Full Text] [Related]  

  • 23. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
    Bahuau M; Vidaud D; Jenkins RB; Bièche I; Kimmel DW; Assouline B; Smith JS; Alderete B; Cayuela JM; Harpey JP; Caille B; Vidaud M
    Cancer Res; 1998 Jun; 58(11):2298-303. PubMed ID: 9622062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
    Kehrer-Sawatzki H; Cooper DN
    J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic basis of tumour development.
    Ponz de Leon M
    Ital J Gastroenterol; 1996 May; 28(4):232-45. PubMed ID: 8842841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phaeochromocytoma in children.
    Armstrong R; Sridhar M; Greenhalgh KL; Howell L; Jones C; Landes C; McPartland JL; Moores C; Losty PD; Didi M
    Arch Dis Child; 2008 Oct; 93(10):899-904. PubMed ID: 18499773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited predisposition to cancer: a historical overview.
    Lynch HT; Shaw TG; Lynch JF
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor genes and their alterations in breast cancer.
    Lee EY
    Semin Cancer Biol; 1995 Jun; 6(3):119-25. PubMed ID: 7495979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of mutations in the TP53 tumor suppressor gene exons 5 to 8 in Fanconi's anemia.
    Jonveaux P; Le Coniat M; Grausz D; Berger R
    Nouv Rev Fr Hematol (1978); 1991; 33(5):343-5. PubMed ID: 1803324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tumor suppressor genes: occurrence, significance and function].
    Scheurlen W; Kreth HW
    Monatsschr Kinderheilkd; 1991 Oct; 139(10):650-4. PubMed ID: 1660097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.
    Marsh DJ; Theodosopoulos G; Howell V; Richardson AL; Benn DE; Proos AL; Eng C; Robinson BG
    Neoplasia; 2001; 3(3):236-44. PubMed ID: 11494117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cancer genetics of TSC2 gene mutant(Eker) rat model].
    Hino O
    Nihon Rinsho; 2000 Jun; 58(6):1255-61. PubMed ID: 10879050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic science and clinical aspects of familial brain tumors].
    Kanno H
    Brain Nerve; 2012 May; 64(5):557-64. PubMed ID: 22570069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor genes and inherited predisposition to malignancy.
    Skuse GR; Rowley PT
    Semin Oncol; 1989 Apr; 16(2):128-37. PubMed ID: 2565603
    [No Abstract]   [Full Text] [Related]  

  • 39. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.
    Whelan AJ; Bartsch D; Goodfellow PJ
    N Engl J Med; 1995 Oct; 333(15):975-7. PubMed ID: 7666917
    [No Abstract]   [Full Text] [Related]  

  • 40. Imaging of cancer predisposition syndromes in children.
    Monsalve J; Kapur J; Malkin D; Babyn PS
    Radiographics; 2011; 31(1):263-80. PubMed ID: 21257945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.